NCT07029035

Brief Summary

The goal of this clinical trial is to learn if a treatment called injectable platelet-rich fibrin (i-PRF) helps improve gum health in people with a type of gum disease called Stage 3 Grade B periodontitis. The main questions this study aims to answer are: Does i-PRF help reduce gum inflammation and support healing? Are there changes in certain biological markers after using i-PRF? Researchers will compare two sides of the mouth. One side will receive i-PRF, and the other will be treated with salt water (saline) as a comparison. Participants will: Have a dental cleaning called scaling and root planing (SRP) Get i-PRF injected into deep gum pockets on one side of the mouth Have salt water placed in the other side's gum pockets Give gum fluid samples and have gum measurements taken at several visits (including 3 months later) Provide a small blood sample to prepare the i-PRF Researchers will collect and study gum fluid and look at markers related to healing and inflammation. The study will help find out if i-PRF is useful as a new treatment option for gum disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 19, 2025

Completed
Last Updated

December 31, 2025

Status Verified

October 1, 2023

Enrollment Period

1 year

First QC Date

May 28, 2025

Last Update Submit

December 26, 2025

Conditions

Keywords

Tgf-βPrfPf 4PeriodontitisPdgfSplit mouthMpoİ-prf

Outcome Measures

Primary Outcomes (2)

  • Changes in GCF levels of TGF-β and PDGF at multiple time points.

    Biochemical markers will be analyzed at baseline, 2 weeks, 4 weeks, and 3 months. The biochemical data will be correlated with clinical periodontal parameters to assess the relationship between molecular changes and clinical outcomes, thereby providing a comprehensive evaluation of treatment efficacy.

    From baseline to third month

  • Changes in clinical periodontal parameters, including Probing Pocket Depth and Clinical Attachment Level, will be evaluated at baseline and at the third month.

    Clinical data will be evaluated at baseline and at the third month.

    From baseline to third month

Secondary Outcomes (2)

  • Changes in GCF levels of PF 4 and MPO at multiple time points.

    From baseline to third month

  • Changes in clinical periodontal parameters, including Plaque Index, Gingival Index, and Bleeding on Probing evaluated at baseline and at the third month.

    From baseline to third month

Study Arms (2)

Test Site

EXPERIMENTAL

Repeated application of İ-PRF to periodontal pockets in the test sites.

Biological: İnjectable platelet-rich fibrin

Control Site

SHAM COMPARATOR

Control sites received a sham intervention consisting of sterile saline solution irrigation into the periodontal pockets, to mimic the procedural aspects of PRF placement without delivering any biologically active material.

Other: Sterile saline (0.9%)

Interventions

Repeated application of I-PRF to the periodontal pockets in the test sites was performed twice: once immediately following scaling and root planing (SRP), and once at the third week.

Test Site

Control sites received a sham intervention consisting of sterile saline solution irrigation into the periodontal pockets, to mimic the procedural aspects of PRF placement without delivering any biologically active material.

Control Site

Eligibility Criteria

Age18 Years - 65 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being diagnosed with Stage 3 Grade B periodontitis
  • Being between the ages of 18-65

You may not qualify if:

  • Smoking
  • Having a systemic disease
  • Taking any medication
  • Being pregnant or breastfeeding
  • Having received chemotherapy, radiotherapy or immunosuppressant treatments
  • Having received periodontal treatment in the last 6 months
  • Having used antibiotics in the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saglik Bilimleri Universitesi Gulhane Dis Hekimligi Fakultesi

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
In addition to masking the participants, the researcher who performed the biochemical analyses was also masked.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This study utilized a split-mouth, within-subject design rather than a classical crossover or parallel group design. Each subject received both the intervention (PRF) and control (no PRF) on different sites of the oral cavity.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2025

First Posted

June 19, 2025

Study Start

December 1, 2023

Primary Completion

December 1, 2024

Study Completion

May 1, 2025

Last Updated

December 31, 2025

Record last verified: 2023-10

Locations